Abionic: FDA approvals and clinical advancements propel life sciences startups forward

Four startups are making strides in developing novel solutions for challenging medical conditions, potentially offering new hope for patients. Alentis Therapeutics and Abionic have received approval from the US Food and Drug administration, paving the way to advance to the next stage. Meanwhile, Anokion and Santhera have recorded positive results from their clinical studies.